Chordate Medical Holding AB (publ) (CMH.ST)
SEK 5.32
(8.65%)
SEK 5.32
(8.65%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -29.18 Million SEK | -4.45% |
| 2022 | -27.94 Million SEK | -28.38% |
| 2021 | -21.76 Million SEK | -10.16% |
| 2020 | -19.75 Million SEK | 20.61% |
| 2019 | -24.88 Million SEK | 6.73% |
| 2018 | -26.68 Million SEK | -14.26% |
| 2017 | -23.35 Million SEK | -70.39% |
| 2016 | -13.7 Million SEK | 15.08% |
| 2015 | -16.14 Million SEK | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -6.01 Million SEK | 38.85% |
| 2024 Q2 | -7.02 Million SEK | -16.68% |
| 2023 Q4 | -9.84 Million SEK | -99.32% |
| 2023 Q1 | -7.11 Million SEK | 11.95% |
| 2023 Q3 | -4.93 Million SEK | 32.28% |
| 2023 Q2 | -7.29 Million SEK | -2.52% |
| 2023 FY | -29.18 Million SEK | -4.45% |
| 2022 Q1 | -7.37 Million SEK | -2.61% |
| 2022 FY | -27.94 Million SEK | -28.38% |
| 2022 Q4 | -8.07 Million SEK | -31.58% |
| 2022 Q3 | -6.13 Million SEK | -2.97% |
| 2022 Q2 | -5.96 Million SEK | 19.2% |
| 2021 FY | -21.76 Million SEK | -10.16% |
| 2021 Q1 | -5.79 Million SEK | -3.78% |
| 2021 Q2 | -5.05 Million SEK | 12.81% |
| 2021 Q3 | -3.71 Million SEK | 26.44% |
| 2021 Q4 | -7.19 Million SEK | -93.35% |
| 2020 Q1 | -5.47 Million SEK | 10.25% |
| 2020 Q4 | -5.58 Million SEK | -29.97% |
| 2020 FY | -19.75 Million SEK | 20.61% |
| 2020 Q3 | -4.29 Million SEK | 2.22% |
| 2020 Q2 | -4.39 Million SEK | 19.69% |
| 2019 FY | -24.88 Million SEK | 6.73% |
| 2019 Q1 | -6.26 Million SEK | 9.25% |
| 2019 Q2 | -6.09 Million SEK | 2.75% |
| 2019 Q3 | -6.42 Million SEK | -5.4% |
| 2019 Q4 | -6.09 Million SEK | 5.07% |
| 2018 Q3 | -6.35 Million SEK | 3.25% |
| 2018 FY | -26.68 Million SEK | -14.26% |
| 2018 Q2 | -6.56 Million SEK | 4.19% |
| 2018 Q1 | -6.85 Million SEK | 7.66% |
| 2018 Q4 | -6.9 Million SEK | -8.69% |
| 2017 Q1 | -4.4 Million SEK | -46.95% |
| 2017 FY | -23.35 Million SEK | -70.39% |
| 2017 Q2 | -5.49 Million SEK | -24.58% |
| 2017 Q3 | -6.02 Million SEK | -9.74% |
| 2017 Q4 | -7.42 Million SEK | -23.16% |
| 2016 Q3 | -4.07 Million SEK | 18.16% |
| 2016 Q2 | -4.97 Million SEK | 0.0% |
| 2016 FY | -13.7 Million SEK | 15.08% |
| 2016 Q4 | -3 Million SEK | 26.36% |
| 2015 FY | -16.14 Million SEK | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acarix AB (publ) | -77.83 Million SEK | 62.504% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 128.2% |
| ADDvise Group AB (publ) | 103.5 Million SEK | 128.2% |
| Arcoma AB | 2.56 Million SEK | 1238.326% |
| Bactiguard Holding AB (publ) | -138.38 Million SEK | 78.909% |
| BICO Group AB (publ) | -835.7 Million SEK | 96.508% |
| Boule Diagnostics AB (publ) | 24.97 Million SEK | 216.854% |
| CellaVision AB (publ) | 130.3 Million SEK | 122.398% |
| Clinical Laserthermia Systems AB (publ) | -79.79 Million SEK | 63.422% |
| C-Rad AB (publ) | 35.52 Million SEK | 182.149% |
| Duearity AB (publ) | -26.19 Million SEK | -11.442% |
| Dignitana AB (publ) | -17.36 Million SEK | -68.097% |
| Episurf Medical AB (publ) | -94.8 Million SEK | 69.212% |
| Getinge AB (publ) | 2.41 Billion SEK | 101.21% |
| Scandinavian Real Heart AB (Publ) | -67.97 Million SEK | 57.064% |
| Iconovo AB (publ) | -45.89 Million SEK | 36.404% |
| Integrum AB (publ) | 4.03 Million SEK | 823.79% |
| Luxbright AB (publ) | -25.37 Million SEK | -15.021% |
| Mentice AB (publ) | -2.81 Million SEK | -936.091% |
| OssDsign AB (publ) | -130.49 Million SEK | 77.634% |
| Paxman AB (publ) | 8.33 Million SEK | 450.38% |
| Promimic AB (publ) | -9.22 Million SEK | -216.49% |
| Qlife Holding AB (publ) | -159.95 Million SEK | 81.753% |
| SciBase Holding AB (publ) | -55.58 Million SEK | 47.492% |
| ScandiDos AB (publ) | -14.64 Million SEK | -99.267% |
| Sectra AB (publ) | 428.38 Million SEK | 106.813% |
| Sedana Medical AB (publ) | -59.61 Million SEK | 51.039% |
| Senzime AB (publ) | -134.14 Million SEK | 78.243% |
| SpectraCure AB (publ) | -20.44 Million SEK | -42.785% |
| Stille AB | 26.64 Million SEK | 209.535% |
| Vitrolife AB (publ) | -3.85 Billion SEK | 99.242% |
| Xvivo Perfusion AB (publ) | 91.82 Million SEK | 131.787% |